跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
美嘉素 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Telmisartan and Hydrochlorothiazide Tablets
Approved
化学药品
Telmisartan and Hydrochlorothiazide Tablets
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Nov 15, 2019
Approval ID
7MaoT8I45U6
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
7MaoT8I45U6
Approval Number
国药准字J20180015
Generic Name
替米沙坦氢氯噻嗪片
Generic Name En
Telmisartan and Hydrochlorothiazide Tablets
Brand Name
美嘉素
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含替米沙坦80mg,氢氯噻嗪12.5mg
Reg Date
2019-11-15
Company Name
Boehringer Ingelheim International GmbH
Company Address
Binger Strasse 173, D-55216 Ingelheim am Rhein, Germany
Production Company Name
boehringer ingelheim ηellas single member s.a.
Production Company Address
5th km Paiania-Markopoulo, Koropi Attiki, 19441, Greece
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 15, 2019
Approval ID
7MaoT8I45U6
Type
化学药品
Back to NMPA Approvals